Skip to content
Search

Latest Stories

PQS deadline extended to ease pressure on community pharmacies

To ease pressure on community pharmacies, the deadline to meet the requirements of the Pharmacy Quality Scheme (PQS) will be extended, Pharmaceutical Services Negotiating Committee (PSNC) announced today (December 15).

This follows an agreement reached between the negotiator and the NHS England and NHS Improvement (NHSE&I) and the Department of Health and Social Care (DHSC).


Recognising the challenges faced by pharmacies and their contribution towards the Covid-19 vaccination programme, following additional changes have been agreed upon:

  • Contractors will not be required to complete the Community Pharmacy Patient Questionnaire for 2021/2022;
  • The requirement for pharmacy teams to complete a national audit (intended to be on valproate) in 2021/22 will be waived; and
  • The requirement for pharmacy teams to complete a contractor-chosen clinical audit in 2021/22 will be waived.

However, pharmacies will still need to make the PQS declaration in February, and as last year, this would be a claim for work to be undertaken and evidenced by June 30, 2022.

PSNC, NHSE&I and DHSC have also agreed to keep the situation under review and more details will be shared later.

Commenting on the agreement, PSNC director of NHS Services Alastair Buxton said: “Community pharmacies are under enormous pressure at the moment, and the ramping up of the Covid-19 booster campaign this week has only exacerbated this. We are therefore pleased to have agreed these measures which should help to reduce some of the workload for contractors in the coming weeks.

The negotiator continues to highlight to the government the “critical work going on in pharmacies – this is having a very positive impact on patients, the public and the NHS, but it is taking its toll on already exhausted pharmacy teams,” he added.

Industry welcomes changes

Many from the sector lauded the new steps, but highlighted huge operational pressures faced by community pharmacies this winter.

Andrew Lane Andrew Lane, chair, NPA

NPA chair, Andrew Lane, said: “We welcome the changes PSNC has negotiated, but it’s very modest compared to the tremendous scale of the workload challenge posed by the Omicron wave.

“This package relieves pharmacies of some background activity, and it’s right that all pharmacies are in scope, not just those directly involved in providing Covid vaccinations.

However, he noted that a lot more needs to be done to free up pharmacy teams for patient care and increase primary care capacity.

Lane said: “NHS England should urgently consider a nationwide emergency supply scheme to reduce the time pharmacies spend chasing up prescriptions. This is already working in Cornwall as a local service and can be switched on elsewhere with minimal fuss.

“The requirement for pharmacies to check codes when people ask for lateral flow tests should also be suspended in light of the prevailing circumstances.”

Despite the agreement, pharmacies still have to face “very challenging few months ahead,” he added.

The Association of Independent Multiple Pharmacies (AIMp) chief executive, Dr Leyla Hannbeck welcomed the extension of PQS deadline. She tweeted:

Screenshot 2021 12 15 at 21 32 41 Leyla Hannbeck on Twitter

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less